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PBRM1 Regulates Stress
Response in Epithelial Cells
Elizabeth G. Porter,1,3 Alisha Dhiman,1,3 Basudev Chowdhury,1 Benjamin C. Carter,1 Hang Lin,1 Jane C. Stewart,1
Majid Kazemian,2 Michael K. Wendt,1 and Emily C. Dykhuizen1,4,*
SUMMARY
Polybromo1 (PBRM1) is a chromatin remodeler subunit highly mutated in cancer, particularly clear cell
renal carcinoma. PBRM1 is a member of the SWI/SNF subcomplex, PBAF (PBRM1-Brg1/Brm-associated factors), and is characterized by six tandem bromodomains. Here we establish a role for
PBRM1 in epithelial cell maintenance through the expression of genes involved in cell adhesion, metabolism, stress response, and apoptosis. In support of a general role for PBRM1 in stress response and
apoptosis, we observe that loss of PBRM1 results in an increase in reactive oxygen species generation
and a decrease in cellular viability under stress conditions. We ﬁnd that loss of PBRM1 promotes cell
growth under favorable conditions but is required for cell survival under conditions of cellular stress.

INTRODUCTION
PBRM1, a gene that encodes a subunit of the PBRM1-Brg1/Brm-associated factors (PBAF) chromatin remodeling complex, is mutated in over 3% of all cancers with the highest mutation rate occurring in clear
cell renal cell carcinoma (ccRCC), where it is mutated in 40%–50% of patients (Cancer Genome Atlas
Research Network, 2013; Peña-Llopis et al., 2012; Varela et al., 2011). The PBAF chromatin remodeling complex is a minor subcomplex of the human SWI/SNF, or BAF, chromatin remodeling family, subunits of which
(SMARCA4 [BRG1], ARID1A, and SMARCB1 [SNF5 or BAF47]) are also frequently mutated in cancers
(Kadoch et al., 2013; Shain and Pollack, 2013). Along with PBRM1, the PBAF subcomplex exclusively contains ARID2, BRD7, BAF45A, as well as several subunits shared with the more abundant BAF complex
(Kaeser et al., 2008; Tatarskiy et al., 2017; Xue et al., 2000). PBRM1 is composed of several domains associated with binding to chromatin including six tandem bromodomains (BDs), two bromo-adjacent homology domains, and a high-mobility group, implicating PBRM1 as a chromatin-targeting subunit of PBAF. For
the most part, the chromatin signatures bound by PBRM1 have not yet been determined, although histone
3 lysine 14 acetylation (H3K14Ac) has been defned as a primary target for the second bromodomain (BD2)
in vitro (Charlop-Powers et al., 2010), and validated as the acetylation mark most critical for association of
the full PBAF complex to histone peptides (Porter and Dykhuizen, 2017). PBRM1 has homology to RSC1,
RSC2, and RSC4 subunits of the yeast RSC chromatin remodeling complex, which also interacts with
H3K14Ac, particularly during DNA damage (Duan and Smerdon, 2014; Wang et al., 2012). However, unlike
subunits of RSC, PBRM1 does not seem to be necessary for viability in the majority of mammalian cell types,
and in fact, although PBRM1 is essential for embryonic heart development in mice (Huang et al., 2008;
Wang et al., 2004), adult mice with knockout of PBRM1 are phenotypically normal except for an age-related
hematopoietic stem cell defect (Lee et al., 2016).
The most well-defned cellular role for PBRM1 is in DNA damage repair (Brownlee et al., 2014; Kakarougkas
et al., 2014), which is in line with observation of H3K14Ac at sites of DNA damage (Lee et al., 2010); however,
the low mutational burden and relative genome stability of PBRM1-mutant tumors makes it unclear how
this role in DNA damage repair relates to the tumor-suppressive phenotypes of PBRM1 (Sato et al.,
2013). As such, most of the focus has been on deciphering how transcriptional functions for PBRM1 relate
to a role in tumor suppression. Transcriptional profling of human ccRCC indicates that PBRM1 mutant tumors have a hypoxic transcriptional signature (Sato et al., 2013), which is in agreement with recent reports
that mutation of PBRM1 amplifes the hypoxia-inducible factor (HIF) transcriptional program signature
induced upon von Hippel-Lindau (VHL) deletion in cell culture (Gao et al., 2017) and in a mouse renal cancer
model (Nargund et al., 2017). Recent work with kidney-specifc (KSP and PAX8) Cre mouse models indicates
that VHL knockout or PBRM1 knockout alone is not suffcient for cancer formation but that both are
required for kidney tumor formation in mice (Espana-Agusti et al., 2017; Gu et al., 2017; Nargund et al.,
2017).
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Although these recent mouse studies have solidifed a role for PBRM1 as a bona fde tumor suppressor in
renal cancer, the molecular mechanism by which PBRM1 acts as a tumor suppressor is still unclear. For
example, PBRM1 exhibits tumor-suppressive phenotypes in a subset of cancer cell lines (Chowdhury
et al., 2016; Huang et al., 2015; Xia et al., 2008), but PBRM1 knockdown in many cell lines produces no
phenotype (Chowdhury et al., 2016; Gao et al., 2017) or even decreases cellular viability (Lee et al.,
2016). In the renal cancer setting, this context-specifc function is mediated, in part, through HIF1a expression, which is required for PBRM1’s tumor suppressor phenotype in renal cell lines (Murakami et al., 2017)
(Shen et al., 2011); however, the context-dependent function observed in other cell types is still undefned.
Here we used epithelial cell lines to defne how the function of PBRM1 in non-transformed cells may relate
to its function as a tumor suppressor. Through genome-wide transcriptional analysis, we have defned a
general role for PBRM1 in regulating the expression of genes involved in stress response, particularly endoplasmic reticulum (ER) stress and apoptosis. To support this general function, we have found that loss of
PBRM1 results in accumulation of reactive oxygen species (ROS) and a failure to induce apoptosis under
a variety of high-stress conditions. Based on our fndings, we propose that PBRM1 acts to regulate stress
response genes that restrain cellular proliferation under low-stress conditions but protect cells under highstress conditions.

RESULTS
Knockdown of PBRM1 in Epithelial Cells Promotes Growth and a Loss of Epithelial Cell
Maintenance
As mutation of PBRM1 in epithelial cells is an early event in tumorigenesis (Gerlinger et al., 2014) we set out
to understand the tumor-suppressive role PBRM1 plays in various cell models of epithelium. We depleted
PBRM1 using lentiviral short hairpin RNA (shRNA) in several epithelial cell lines including the immortalized
human kidney epithelial cell line HK-2, the canine kidney epithelial cell line MDCK, and the mouse mammary epithelial cell line NMuMG (Figure S1A). In addition to its role in renal cancer, PBRM1 acts as a tumor
suppressor in mammary-epithelium-derived cancers as observed in PBRM1-mutated (Xia et al., 2008) and
PBRM1-downregulated breast cancers (Figure S1B) (Mo et al., 2015). The loss of PBRM1 resulted in an increase in proliferation in all of these cell lines (Figure 1A). As NMuMG is the most commonly used cell
model of epithelial differentiation, we used it for further analysis and validated the PBRM1 knockdown
phenotype using CRISPR-mediated knockout of PBRM1 (Figures 1A and S1C). In NMuMG cells, knockdown
of PBRM1 decreases protein levels of E-cadherin, a marker of epithelial cells, and increases vimentin, a
marker of mesenchymal cells (Figure 1B) (Kalluri and Weinberg, 2009). A decrease in E-cadherin at adherens junctions results in a weakening of cell-cell adhesion and also results in the release of bound b-catenin,
which normally anchors E-cadherin to the actin cytoskeleton (Kalluri and Weinberg, 2009). In agreement
with this, we observed an increase in nuclear b-catenin signaling upon PBRM1 knockdown (Figure 1C).
The complete loss of E-cadherin expression and cellular morphology characteristic of a robust epithelial-to-mesenchymal transition (EMT) was not observed; instead, the observed phenotypes refect a partial
EMT or a reduction in epithelial maintenance. The same phenotypes were also observed upon knockdown
of BRD7, another PBAF-specifc subunit (Kaeser et al., 2008), although these fndings are complicated by a
decrease in PBRM1 upon BRD7 knockdown (Figure S1D). Consistent with the documented role for the BAF
complex in maintaining human mammary epithelial proliferation (Cohet et al., 2010), knockdown of BAF
subunits ARID1A or BRG1 resulted in cell arrest and death (data not shown).
A decrease in E-cadherin in epithelial cells during EMT results in a weakening of cell-cell contacts, resulting
in an increase in migration rates, which was observed in the PBRM1 knockdown (Figure 1D) and PBRM1
knockout (Figure S1E). A decrease in E-cadherin also results in a decrease in cellular polarity, a feature central to epithelial function. To investigate the contribution of PBRM1 to the maintenance of epithelial cell
polarity we plated NMuMG cells in Matrigel-based 3D culture where they self-assemble into luminal structures consisting of hollow acini displaying apical-basal polarity (Hall et al., 1982). Upon PBRM1 knockdown,
the spheres fail to establish hollow lumen and lose both ZO-1 at apical tight junctions and basal or lateral
staining of alpha 6 integrin (Figures 1E and S1F). This phenotype is consistent with that observed in
NMuMG epithelial cells with PTEN deletion or PI3K-activating mutation (Berglund et al., 2012).

PBRM1 Regulates Genes Involved in Cell Adhesion, Signaling, Stress Response, and
Apoptosis
To identify genes regulated by PBRM1 in epithelial cells, we performed RNA sequencing (RNA-seq) from
control and PBRM1 knockdown NMuMG cells. In total, we identifed 2,467 genes with signifcantly
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Figure 1. Knockdown of PBRM1 in Cell Line Models of Epithelial Differentiation Promotes Growth and a Loss of
Epithelial Cell Maintenance
(A) Epithelial cell lines HK-2 (human kidney), MDCK (canine kidney), and NMuMG (mouse mammary), were counted after
72 h growth, and cell number are presented as mean G SD. n = 3–5.
(B) Immunoblot analysis of whole-cell lysates from NMuMG cells indicates that PBRM1 knockdown results in decreased
E-cadherin and increased vimentin expression. Quantifcation represented as percent of shPBRM1 over vector.
(C) b-Catenin signaling, as measured using TopFlash reporter assay in NMuMG cells with vector control or shPBRM1.
Individual replicates are presented as mean G SD, n = 8.
(D) Migration differences determined by measuring the cell-free area at 403 magnifcation at 0 and 8 h after scratching
with standard pipette tip. The data from 12 independent images were statistically analyzed and presented as mean G SD,
n = 12.
(E) Acini with hollow lumen from NMuMG cells grown in 3D culture for 10 days were counted in a blinded manner, and the
frequency was calculated from total acini in a feld of image (average of 5–6 acini per feld). The data from 11 independent
images were statistically analyzed (Student’s t test) and presented as mean G SD, n = 11. Representative image of acini
grown for 14 days were analyzed using immunofuorescence staining with anti-ZO1 (red) and anti-alpha-6-integrin
(green). Nuclei (blue) were visualized by DAPI.
**p < 0.01, ***p < 0.001, ****p < 0.0001 (paired Student’s t test). ns, not signifcant. Error bars represent SD. Also see
Figure S1.
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Figure 2. PBRM1 Regulates Genes Involved in Cell Adhesion, Signaling, Stress Response, and Apoptosis and Is Predicted to Cooperate with
Transcription Factors Involved in Response to Stress
(A) Top overrepresented biological process GO terms (p values < 10 10) for differentially expressed genes that are downregulated in NMuMG cells with
shPBRM1.
(B) Top overrepresented biological process GO terms (p values < 10 10) for differentially expressed genes that are upregulated in NMuMG cells with
shPBRM1.
(C) Putative transcription factors were identifed for genes exhibiting differential expression in NMuMG cells with shPBRM1.
(D) Heatmaps of regions identifed as differentially accessible with PBRM1 knockdown using ATAC-seq analysis of NMuMG cells. Regions of at least 1.5-fold
differential accessibility were calculated between pooled samples of three biological replicates.
(E) Metagene plots of the regions identifed as differentially accessible with PBRM1 knockdown using ATAC-seq analysis of NMuMG cells.
(F) Genomic elements associated with the differentially accessible peaks. The overall distribution was calculated as a percentage of the total differentially
accessible regions for each condition.
(G) Motif analysis was performed using HOMER for the differentially accessible peaks. Statistically signifcant motifs were identifed based on relative
enrichment over genomic areas with similar AT content.
(H) The contribution of PBRM1 to the transcriptional regulation of NRF2 (left) or c-Jun (right) target genes using qRT-PCR and OAZ1 as the housekeeping
gene. n = 3. *p < 0.05, **p < 0.01, ***p < 0.001 (paired Student’s t test). Error bars represent SD.
Also see Figure S2 and Table S1.

increased transcript levels and 1,927 genes with signifcantly decreased transcript levels upon PBRM1
knockdown (Table S1). Gene ontology (GO) analysis identifed numerous pathways signifcantly enriched
in genes downregulated upon shPBRM1, including cell movement, cell structure, development, and
signaling (Figure 2A), as would be expected based on the loss of epithelial characteristics in the PBRM1
knockdown (Figure 1). In addition, there were numerous enriched biological pathways involved in stress
response, cellular homeostasis, translational elongation, and apoptosis. In contrast, there were few
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signifcantly enriched biological pathways for genes upregulated upon PBRM1 knockdown; however, these
pathways included microtubule-based processes (Figure 2B).

PBRM1 Is Predicted to Cooperate with Transcription Factors that Facilitate the Response to
Stress
We further utilized the RNA-seq datasets to predict upstream regulators that might cooperate with PBRM1
in the transcription of target genes. For genes decreased with shPBRM1, several enriched consensus sequences were identifed, with the most robust identifed for KLF transcription factors (TFs), including
KLF4 (Figure 2C), which is required for epithelial cell homeostasis (Ghaleb et al., 2011; Yu et al., 2012). In
fact, the KLF4 knockdown in NMuMG cells has a similar phenotype to the PBRM1 knockdown (Tiwari
et al., 2013). In addition, there was signifcant enrichment for genes with consensus sequences for ETS
TFs, which are primarily thought of as oncogenic, but are involved in a variety of processes like cell cycle,
differentiation, and apoptosis (Sizemore et al., 2017). Last, there was signifcant enrichment for genes
with consensus sequences for AP-1 TFs, such as JUN/FOS and NRF2, which are upregulated during stress
(Jiang et al., 2016; Rössler and Thiel, 2017). Similar to the RNA-seq analysis, very few TF consensus
sequences were enriched in the promoters of genes upregulated upon shPBRM1, but the main consensus
sequences enriched were associated with MBTPS2 (Figure 2C), a protease that activates TFs involved in
cholesterol synthesis and ER stress response (Rawson, 2013), and YY1, a structural protein involved in promoter-enhancer associations (Beagan et al., 2017).
To further defne whether these putative TFs are directly regulated by PBRM1’s chromatin remodeling
function, we next turned to Assay for Transposase-Accessible Chromatin (ATAC)-seq to identify sites
of PBRM1-dependent chromatin accessibility. As observed elsewhere (Gao et al., 2017), PBRM1 knockdown did not have dramatic effects on global chromatin accessibility. It did, however, result in a significant decrease in accessibility (at least 1.5-fold) at 5,245 sites and increased accessibility at 6,790 in
NMuMG cells (Figures 2D and 2E) with similar genomic distributions (Figure 2F). Similar results were obtained using PBRM1 knockdown in HK-2 epithelial cells (Figures S2A and S2B). To identify TFs that are
potentially dependent on PBRM1 for chromatin binding, we calculated the enrichment of TF consensus
binding sequences at sites with differential accessibility upon PBRM1 knockdown (Figures 2G and S2C).
Several TF consensus sequences were signifcantly enriched compared with background at sites of
increased and decreased accessibility upon shPBRM1. Consensus sequences for KLF, AP-1, ETS,
FOXO, and NF-kB TFs were highly enriched in regions with decreased accessibility upon shPBRM1,
which correlates with the predicted regulators based on RNA-seq data (Figure 2C). In addition, there
was a signifcant overlap between genes downregulated upon shPBRM1 and genes with an associated
region of decreased accessibility (536 genes, p = 4.5x10 83) and these regions displayed enrichment
for KLF, AP-1, ETS, and FOXO consensus sequences. Although we observed similar enrichment of
consensus sequence-binding sites in the regions with increased accessibility upon shPBRM1, the regions
of accessibility did not correlate with genes upregulated upon shPBRM1 (144 genes, p = 0.455). As many
of the biological pathways identifed were related to apoptosis and stress response, we investigated the
cooperation between PBRM1 and c-Jun and NRF2, two TFs that are activated during stress (Jiang et al.,
2016; Rössler and Thiel, 2017) (Figure 2H). Using lentiviral-mediated shRNA knockdown, we found that
similar to the PBRM1 knockout, knockdown of c-Jun (but not NRF2) increased proliferation (S2D). Using
a publicly available dataset of NRF2 bound and regulated genes in A549 lung cancer cell lines
(GSE113497), we identifed 36 NRF2 targets that are also differentially expressed in the PBRM1 knockdown and have associated sites of decreased chromatin accessibility in the shPBRM1 ATAC-seq. Intriguingly, these included canonical NRF2 target antioxidant genes HMOX1 and NQO1 (Chorley et al., 2012).
Using qRT-PCR we confrmed NRF2 knockdown and evaluated the requirement for PBRM1 on expression
of these genes (Figure 2H, left). In contrast to many published reports, HMOX1 did not show a dependence on NRF2 for expression, although it was dependent on PBRM1. As expected, NQO1 was dependent on both NRF2 and PBRM1 for expression. In the absence of comprehensive c-Jun datasets, we
selected several putative c-Jun targets from c-Jun N-terminal kinase (JNK)-dependent genes identifed
in previous studies. These include BCL2L1, an anti-apoptotic regulator (Girnius and Davis, 2017);
HK2, a metabolic enzyme and anti-apoptotic regulator (Insua-Rodrı́guez et al., 2018); and IL1RL1, an
anti-infammatory interleukin (IL)-33 receptor (Kim et al., 2015). We confrmed c-Jun knockdown in
NMuMG cells using qRT-PCR and validated that these genes are regulated by both PBRM1 and c-Jun
(Figure 2H, right). In summary, genes affected by PBRM1 knockdown are targets of TFs involved in
response to stress.
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Figure 3. Knockdown of PBRM1 Results in Elevated ROS under Cellular Stress Conditions
(A) NMuMG cells were trypsinized and stained for 30 min with H2-DCFDA, washed with PBS, and analyzed using fow cytometry. The mean fuorescence value
for 10,000 cells was calculated from four independent experiments.
(B) NMuMG cells grown in 96-well plates were treated with increasing concentrations of H2O2 for 1 h, washed with PBS, and incubated with H2-DCFDA for
30 min. Reagent was washed away, and the DCF fuorescence was measured in live cells.
(C) NMuMG cells grown in 96-well plates were treated with media containing varying concentrations of glucose (normal media = 25 mM) for 16 h, washed
with PBS, and incubated with H2-DCFDA for 30 min. Reagent was washed away, and the DCF fuorescence was measured in live cells.
(D) NMuMG cells grown in 96-well plates were treated with media containing varying concentrations of CoCl2 for 24 h, washed with PBS, and incubated with
H2-DCFDA for 30 min. Reagent was washed away, and the DCF fuorescence was measured in live cells.
(E) NMuMG cells grown in 96-well plates were treated with media containing varying concentrations of doxorubicin for 24 h, washed with PBS, and incubated
with H2-DCFDA for 30 min. Reagent was washed away, and the DCF fuorescence was measured in live cells.
*p < 0.05, **p < 0.01, ***p < 0.001 (paired Student’s t test). ns, not signifcant. Error bars represent S.D.

Knockdown of PBRM1 Results in Elevated ROS under Cellular Stress Conditions
Owing to the transcriptional signature indicating an increased importance for PBRM1 in regulating genes
involved in stress response, we next examined how depletion of PBRM1 affects ROS, which are generated
by cells under a variety of cellular stresses (Geou-Yarh Liou, 2010). NMuMG cells have low endogenous ROS
levels, and PBRM1 knockdown results in a small but signifcant increase in ROS under normal cell culture
conditions (Figure 3A), as measured by conversion of 20 ,70 -dichlorodihydrofuorescein diacetate
(H2DCFDA) to the highly fuorescent 20 ,70 -dichlorofuorescein (DCF) by intracellular ROS. To understand
the effects of PBRM1 on ROS under high cellular stress, we looked at ROS levels after recovery from
hydrogen peroxide treatment (Figure 3B), glucose deprivation (Figure 3C), hypoxia-inducing CoCl2 treatment (Figure 3D), and DNA-damaging doxorubicin treatment (Figure 3E). Under all these stress conditions,
cells lacking PBRM1 expression displayed increased levels of ROS.

PBRM1 Expression Is Cytoprotective under High-Stress Conditions
A low-level increase in ROS production promotes cancer progression by stimulating signaling, and facilitating transformation through increasing genomic instability and infammation (Figure 4A) (Geou-Yarh
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Figure 4. PBRM1 Expression Is Cytoprotective under High-Stress Conditions
PBRM1 induces apoptotic pathways and increases cellular viability under high-cellular-stress conditions.
(A) Depiction of the multifaceted role ROS regulators play in cancer.
(B) NMuMG cells were cultured in normal cell media or 250 mM H2O2 for 16 h, and the number of live cells were counted using trypan blue.
(C) Annexin V staining was measured in NMuMG cells treated with 200 mM H2O2 for the indicated times. The percentage of annexin V-positive cells was
calculated for two independent experiments.
(D) Whole-cell lysates were prepared from NMuMG cells treated with 200 mM H2O2 for the indicated times and probed for the indicated proteins using
immunoblot analysis.
(E) LDH release was measured from 10 mL media using LDH Cytotoxicity Assay Kit II (Abcam).
*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 (paired Student’s t test). ns, not signifcant. Error bars represent SD. Also see Figure S3.

Liou, 2010). In addition, ROS can increase AKT phosphorylation and induce changes in cell adhesion molecules to increase motility (Geou-Yarh Liou, 2010), both of which we observed previously in Caki2 renal cancer cells without PBRM1 (Chowdhury et al., 2016) and in epithelial cells lacking PBRM1 (Figure S1A).
Although increases in ROS are characteristic in cancer and contribute to transformation and oncogenesis,
cancer cells need to avoid extremely high levels of ROS due to cytotoxicity (Figure 4A) (Geou-Yarh Liou,
2010). To understand how PBRM1-regulated ROS levels under high-stress conditions affect cellular
viability, we measured cell survival after high concentrations of hydrogen peroxide for 16 h. We found
that PBRM1 knockdown decreased viability under these high-stress conditions in the NMuMG (Figure 4B)
and MDCK epithelial cells (Figure S3A), an effect observed similarly with the NRF2 knockdown (Figure S3B).
This was not due to increased apoptosis in the PBRM1 knockdown, and in fact, cells lacking PBRM1 displayed a defciency in annexin V (Figure 4C) and cleaved PARP (Figures 4D and S3C) under stress conditions. This is in line with the transcriptional role for PBRM1 in regulating pro-apoptotic genes (Figure 2A).
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Although it seems counterintuitive that PBRM1-expressing cells have both increased apoptosis and
increased cell survival under high-stress conditions, it is consistent with a role for PBRM1 in the stress
response, which often results in apoptosis if cellular stresses are not resolved. In contrast, cells lacking
PBRM1 are unable to mount a proper response to external stress, leading to high ROS levels and cell death
through other means, such as necrosis (Fulda et al., 2010), which is supported by the increase in necrosis
marker lactate dehydrogenase (LDH) in the NMuMG cells lacking PBRM1 (Figure 4E).

PBRM1-Regulated Transcriptional Effects under Cellular Stress Conditions
To determine if the dependency on PBRM1 expression for viability under stress conditions is due to
PBRM1’s regulation of different genes under stress conditions, we characterized the transcriptional profle
of NMuMG cells with and without PBRM1 knockdown, grown in H2O2 (200 mM) for 2 h or low-glucose media
for 6 h. There were between 1,000 and 2,000 differentially expressed genes (DEGs) identifed in cells grown
in H2O2 or low-glucose growth conditions for both vector control and shPBRM1 cells (Table S1); however,
the impact of PBRM1 knockdown on overall gene expression was more signifcant than the impact of either
stress conditions (Figure 5A). We observed a signifcant correlation between gene expression changes
induced by PBRM1 knockdown in different stress conditions (Figure S4A), and a signifcant correlation between gene expression changes induced by stress conditions in the two cell lines (vector and shPBRM1)
(Figure S4B) indicating that many genes altered by stress are not dependent on PBRM1 and many genes
dependent on PBRM1 are not altered by stress (Figure S4C). In addition, we observed a signifcant correlation between gene expression changes induced by the two different stress conditions (Figure S4C). As
expected, the signifcantly enriched GO terms were similar for genes regulated by PBRM1 under stress
treatment compared with untreated cells; however, more genes from pathways involved in cell adhesion,
signaling, and apoptosis were altered upon shPBRM1 under stress treatments (Figure 5B). Furthermore, we
observed several GO terms that were signifcantly enriched only for genes downregulated with shPBRM1
under either stress treatment, including cell cycle, protein metabolic processes, and cellular response to
stress, and for genes downregulated upon shPBRM1 only under H2O2 treatment, such as RNA processing
and DNA damage response (Figure 5C). Accordingly, there were many genes dependent on PBRM1
expression for induction under H2O2 stress (Figure 5D), many of which are involved in cell adhesion,
apoptosis, ER stress, and antioxidant response. We used this dataset to identify the NRF2 and c-Jun targets
from Figure 2 that were induced under H2O2 stress. c-Jun target, IL1RL1, an IL-33 receptor involved in protection from stress (Kim et al., 2015), requires both PBRM1 and c-Jun for induction upon H2O2 treatment
(Figure 5E). Similarly, the antioxidant NRF2 targets, HMOX1 and NQO1, are induced upon H2O2 treatment
and require PBRM1 and/or NRF2 for full gene induction (Figure 5F). In conclusion, the RNA-seq analysis of
PBRM1-dependent gene expression under stress conditions supports a role for PBRM1 in inducing a subset
of stress response genes to promote cell survival under conditions of high stress.

PBRM1 Has Cell-Type-Speciﬁc Roles in Viability
After establishing that PBRM1 knockdown can have different effects on viability depending on the stress
environment, we re-evaluated the premature senescence phenotype previously described for PBRM1
knockout in mouse embryonic fbroblasts (MEFs) (Lee et al., 2016). We confrmed that PBRM1 knockdown
(Figure S5A) results in a loss in the proliferative capacity of MEFs (Figure 6A) similar to published fndings
with the PBRM1 conditional knockout (Lee et al., 2016). We next observed a signifcant increase in ROS
levels and H2O2 levels in MEFs upon PBRM1 knockdown (Figure 6B and S5B), which was most similar to
the robust increase in ROS levels observed in shPBRM1 NMuMG cells grown under high-stress conditions.
This particular sensitivity of MEFs to PBRM1 knockdown is most likely due to the unique susceptibility of
MEFs to oxidative stress from high oxygen content in air (Espana-Agusti et al., 2017). To support this,
we found that exogenous antioxidants such as vitamin C (Figure 6C) or N-acetylcysteine (Figure S5C)
were able to reverse the viability defect induced by PBRM1 knockdown in MEFs.
We next sought to examine how intrinsic genetic changes could alter dependency on PBRM1. To do this we
employed the MCF10A human mammary epithelial cell line (Soule et al., 1990), and the MCF10A-T1k cell
line, which has been transformed with T24-HRas and passaged in a mouse (Dawson et al., 1996). We
knocked down PBRM1 in both these cell lines (Figure S6A) and found dramatically different effects on
viability. Similar to other epithelial cell lines, PBRM1 knockdown in MCF10A results in an increase in proliferation and a slight increase in ROS (Figure 6D), with some, but not all, of the same changes in gene expression compared with PBRM1 knockdown in NMuMG cells (Figure S6B), In contrast, PBRM1 knockdown in the
MCF10A-T1k cell line is highly deleterious to viability, causing cells to cease proliferation altogether within
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(E) Transformed human mammary cell line MCF10A-T1k was counted after 72 h growth using trypan blue to eliminate dead cells (left), and data are presented
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*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 (paired Student’s t test). ns, not signifcant. Error bars represent SD. Also see Figures S5 and S6.
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three to four passages (Figure 6E, left). Similar to MEFs, PBRM1 knockdown in this line induces a highly signifcant increase in ROS levels (Figure 6E, right), and similar to MEFs, vitamin C administration can partially
restore proliferative capacity in the PBRM1 knockdown (Figure 6F). The oncogene-induced stress in the
MCF10A-T1k cell line promotes dependency on PBRM1 for viability, which may be refected in its increased
level of ROS at baseline compared with MCF10A cells (Figure S6C). In summary, our data up to this point
establish that PBRM1 knockdown can have different effects on viability in the same cell line due to different
external stress environments, or in two different cell lines due to cell type susceptibilities to stress.

PBRM1 Displays Stress Response Phenotype in Renal Cancer Cells
To begin to decipher how the stress response functions observed for PBRM1 in epithelial cells might relate
to its role in renal carcinoma, we frst determined the enriched GO terms for the genes with decreased
expression in patients with PBRM1 mutations, which were similar to the pathways observed in the NMuMG
cells, including cell adhesion, neuronal processes, apoptosis, and ER stress or proteolysis (Figure S7A).
Furthermore, we compared the differentially regulated genes and observed the most signifcant gene
overlap between genes with decreased expression in patients with PBRM1 mutations and genes with
decreased expression in the PBRM1 knockdown (S7B), similar to the overlaps we observed with Caki2 cells,
a renal carcinoma cell line with loss-of-function mutations in PBRM1 (Chowdhury et al., 2016). Therefore we
used Caki2 ccRCC cell lines with PBRM1 re-expression to determine if the same phenotypes are observed
in the renal cancer setting. Previously we have shown that re-expression of PBRM1 decreases growth and
migration of Caki2 cells (Chowdhury et al., 2016). When we used DCF staining to determine ROS levels, we
observed highly elevated ROS compared with the epithelial cells, which is consistent with previous observations about high ROS in cancer cell lines (Geou-Yarh Liou, 2010) (Figures 3A and 7A). However, the reexpression of PBRM1 only reduced ROS levels to a very slight degree under normal cell culture conditions
(Figure 7A). In contrast to the NMuMG cells, high-stress conditions in Caki2 cells did not result in an increase in ROS levels in the absence of PBRM1; however, in the presence of PBRM1, high-stress conditions
induced a dramatic decrease in ROS levels (Figures 7B and 7C). Furthermore, PBRM1 re-expression promoted cell survival under high-stress conditions (Figure 7D), similar to the phenotype observed in NMuMG
cells (Figure 4B). Also similar to the phenotype observed in NMuMG cells, Caki2 cells with PBRM1 reexpression display a greater increase in cleaved PARP, an apoptosis marker, under hydrogen peroxide
treatment conditions (Figure 7E). Activation of apoptosis seems conficting with PBRM1’s role in survival,
whereas it is consistent with a role for PBRM1 in activating stress response pathways that eventually lead
to apoptosis under continued cellular stress (Fulda et al., 2010). In contrast, Caki2 cells lacking PBRM1
display an increase in LDH when exposed to H2O2 stress, indicative of eventual necrosis from failing to
properly activate stress response pathways (Figure 7F).

DISCUSSION
Chromatin regulators are frequently misregulated in cancer with resulting alterations in gene transcription;
however, many of these regulators alter a large number of genes to a small degree and can regulate very
different sets of genes in different cell lines. An additional challenge resides in the fact that many chromatin
regulators modulate transcription differently depending on environmental inputs (Johnson and Dent,
2013). Thus it has been incredibly challenging to decipher how the transcriptional effects of chromatin regulators observed in a particular cell line relate to its general biochemical function or its phenotype in vivo.
Traditional cell culture models are often devoid of the environmental stimuli chromatin regulators normally
sense, making it a signifcant challenge to develop a relevant cell culture model for accurately studying
these regulators. Here, we have used transcriptional analysis of epithelial cells with PBRM1 knockdown
to identify pathways involved in epithelial cell maintenance and stress response. In addition, we have validated a role for PBRM1 in the maintenance of epithelial cell identity and identifed KLF, AP-1, and ETS TFs
consensus sequences in both genes downregulated upon shPBRM1 and regions with decreased chromatin
accessibility upon shPBRM1. From this, we have validated a role for PBRM1 in facilitating the transcription
of c-Jun and NRF2 target genes, restraining ROS production and inducing both apoptotic and cell survival
pathways under high-stress conditions (Roupé et al., 2014; Wang et al., 2014).
In addition to changes in TF expression and localization during cellular stress, oxidative stress and metabolic stress are known to specifcally upregulate H3K14Ac at stress response genes (Schram et al., 2013), a
histone mark specifcally recognized by PBRM1 (Porter and Dykhuizen, 2017). H3K14Ac is generally found at
active promoters with H3K9Ac, whereas it is found without H3K9Ac at inducible genes (Karmodiya et al.,
2012) and is specifcally increased in gene bodies during stress (Johnsson et al., 2009). H3K14Ac is also a
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Figure 7. PBRM1 Displays Stress Response Phenotype in Renal Cancer Cells
PBRM1 regulates stress response in renal carcinoma cells.
(A) Caki2 cells were trypsinized and stained for 30 min with H2-DCFDA, washed with PBS, and analyzed using fow cytometry. The mean fuorescence value for
10,000 cells was calculated from seven independent experiments.
(B) Caki2 cells grown in 96-well plates were treated with increasing concentrations of H2O2 for 1 h, washed with PBS, and incubated with H2-DCFDA for
30 min. Reagent was washed away, and the DCF fuorescence was measured in live cells.
(C) Caki2 cells grown in 96-well plates were treated with glucose-free media for varying time periods, washed with PBS, and incubated with H2-DCFDA for
30 min. Reagent was washed away, and the DCF fuorescence was measured in live cells.
(D) Caki2 cells were cultured in normal cell media or 200 mM H2O2 for 16 h, and the cell viability was estimated using crystal violet staining.
(E) Whole-cell lysates were prepared from Caki2 cells treated with 200 mM H2O2 or 100 mM camptothecin for 2 h, and relative levels of indicated proteins were
probed using immunoblot analysis. Irrelevant lane was spliced out.
(F) LDH release was measured from 10 mL media using LDH Cytotoxicity Assay Kit II (Abcam).
*p < 0.05, ***p < 0.001, ****p < 0.0001 (paired Student’s t test). ns, not signifcant. Error bars represent SD. Also see Figure S7.

mark associated with renal epithelium adaptation to oxidative stress (Mahalingaiah et al., 2016, 2015), highfat-diet-induced infammation in rodents (Suter et al., 2012), ER stress (Dicks et al., 2015), and sites of DNA
damage (Chiu et al., 2017), a process for which PBRM1 has a well-established role (Kakarougkas et al., 2014).
Therefore specifc patterns of histone acetylation likely delineate a subset of stress response genes targeted by PBRM1, which is likely to be unique for a particular cell type, as well as a particular stressor.
A role for PBRM1 in stress response is in agreement with recent fndings that PBRM1 deletion alone is not
suffcient for transformation but acts to facilitate oncogenesis in cooperation with VHL deletion (EspanaAgusti et al., 2017; Gu et al., 2017; Nargund et al., 2017). PBRM1 deletion allows for an amplifcation of
oncogenic signaling (Gao et al., 2017; Nargund et al., 2017), as well as a bypass of checkpoints induced
by replication stress after VHL deletion (Espana-Agusti et al., 2017). This could be in part due to PBRM1’s
role in regulating the hypoxic stress response in cooperation with HIF1a, which allows for the reduction of
ROS and induction of apoptosis in response to hypoxia (Kim et al., 2006).
A role in stress response is likely part of PBRM1’s function as a tumor suppressor during cancer initiation,
and it may also be involved in PBRM1’s protective function against cancer therapeutics, similar to the
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protective role PBRM1 plays under high-stress conditions. Patients with ccRCC with PBRM1 mutations tend
to have favorable prognosis (Piva et al., 2015), and recent studies indicate that PBRM1 mutant tumors
respond particularly well to sunitinib (Beuselinck et al., 2017) and PD-1 inhibitors (Miao et al., 2018). In support of this, a recent CRISPR-Cas9 screen identifed PBRM1, along with other PBAF-specifc subunits, as
resistance factors against T cell-mediated killing (Pan et al., 2018). This is related to a general role for
PBRM1 in suppressing the infammatory response, as PBRM1 deletion also increases innate immunity hyperinfammation in the gut (He et al., 2017; Shu et al., 2017). The general role for PBRM1 in stress response
could relate to PBRM1’s role in suppressing infammation (and T cell-mediated toxicity) through the regulation of homeostasis (Chovatiya and Medzhitov, 2014), although that connection will need to be explored
further.

Limitations of Study
Using epithelial cell lines, we have defned a role for PBRM1 in mediating the expression of stress
response genes. Although this fnding unifes the disparate results previously published regarding
PBRM1’s cellular function and provides a framework for future studies, it does not provide a precise
mechanism for PBRM1’s function. In addition, although we observe similar functions for PBRM1 in a
renal cancer cell line, our work does not make any conclusions about whether PBRM1’s role in the transcription of stress response genes is its primary function as a tumor suppressor during renal carcinoma
progression. Lastly, although a transcriptional role in stress response is typical for chromatin regulators
involved in DNA damage repair (Gregersen and Svejstrup, 2018), we have not defned here whether the
observed role for PBRM1 in upregulating stress response genes is truly independent from its role in DNA
damage repair. Additional mechanistic work will be required to dissect these functions on a molecular
level.

METHODS
All methods can be found in the accompanying Transparent Methods supplemental fle.
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*** = p < 0.001, **** = p < 0.0001 (paired Student’s t test). ns, not significant. Error bars represent S.D.
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S4: PBRM1-regulated transcriptional effects under cellular stress conditions. Related to
Figure 5 and Table 1. A. Each data point represents the log2 fold change expression value of a single
gene, Left and Center plots- x axis: differential expression in H2O2 treated cells (left) or low glucose
treated cells (center) upon shPBRM1, y axis: differential expression in normal cell culture conditions upon
shPBRM1 (left and center); Right plot- x axis: differential expression under low glucose stress, y axis:
differential expression under H2O2 stress. The degree of correlation was calculated using all differentially
expressed genes. B. Each data point represents the log2 fold change expression value of a single gene
upon 2h H2O2 treatment (left) or 6h low glucose treatment (right), x axis: differential expression in
shPBRM1, y axis: differential expression in vector control cells. The degree of correlation was calculated
using all differentially expressed genes. C. Each data point represents the log2 fold change expression
value of a single gene upon 2h H2O2 treatment (y axis) or 6h low glucose treatment (x axis) of vector
control cells (left) or shPBRM1 cells (right).
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S5: PBRM1 has cell-type specific roles on viability. Related to Figure 6. A. PBRM1 knockdown in
MEFs was analyzed using immunoblot analysis of nuclear lysates. B. Hydrogen peroxide levels were
quantitated in MEFs using Amplex® Red Hydrogen Peroxide/Peroxidase Assay Kit. Whole cell lysates
were generated from the indicated number of cells in 50 µL RIPA. C. MEFs were cultured for 3 days in
normal media or media supplemented with 500 µM NAC. Luminescence was measured using CellTiterGlo® assay system and data presented as mean ± SD. n = 4. *=p <0.05, ** = p <0.01, *** = p < 0.001,
**** = p < 0.0001 (paired Student’s t test). ns, not significant. Error bars represent S.D.
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S6: PBRM1 has cell-type specific roles on viability. Related to Figure 6. A. PBRM1 knockdown in
MCF10A and MCF10A-T1k cell lines was analyzed using immunoblot analysis of nuclear lysates.
Quantification indicates the intensity of PBRM1 staining over LaminB1. B. Comparison of the expression
changes of ATF3, BMF, IGFBP4 and BCL2 in PBRM1 knockdown in mouse mammary epithelial cells
(NMuMG: RNA-seq) with human mammary epithelial cells (MCF10A: qPCR). C. ROS levels for MCF10A
and MCF10A-T1k cells were determined using H2-DCFDA by flow cytometry. *=p <0.05, ** = p <0.01, ***
= p < 0.001, **** = p < 0.0001 (paired Student’s t test). ns, not significant. Error bars represent S.D.
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S7: Pathways deregulated upon PBRM1 knockdown in NMuMG cells correlate with TCGA patient
dataset. Related to Figure 7. A. Summary of genes with decreased expression in renal clear cell
carcinoma patients with PBRM1 mutations from The Cancer Genome Atlas (TCGA). B. Overlap of
differentially regulated genes in NMuMG cells and TCGA patient data. Summary of genes with decreased
expression in both NMuMG shPBRM1 and patients with PBRM1 mutations.

TRANSPARENT METHODS
Cell culture
HK-2 were purchased from ATCC and used within 6 months of purchase and 15 passages. Cells were
cultured in RPMI (Corning Mediatech) supplemented with 10% fetal bovine serum (J R Scientific), 1%
antibiotics (100 units/ml penicillin and 100 g/ml streptomycin; Corning Mediatech), and 1% L-glutamine
(Corning Mediatech) at 37 °C in a humidified atmosphere in a 5% CO2 incubator.
MEF cells were derived from E13.5 day embryos harvested from pregnant 129 mice. Heads and organs
were removed and the rest of the embryo was dissociated in trypsin and DNAseI and cultured for 2
passages before performing knockdowns. Cells were cultured in DMEM (Corning Mediatech)
supplemented with 10% fetal bovine serum (J R Scientific), 1% antibiotics (100 units/ml penicillin and
100g/ml streptomycin; Corning Mediatech), 1% nonessential amino acids (Corning Mediatech), 1% Lglutamine (Corning Mediatech) and 0.1% b-mercaptoethanol (Gibco, Thermo Scientific) at 37 °C in a
humidified atmosphere in a 5% CO2 incubator.
MCF10A cells were authenticated by STR DNA profiling at Bio-Synthesis (Lewisville, TX) and cultured in
1:1 DMEM (Corning Mediatech) and F12 (Corning Mediatech) supplemented with 29 mM Hepes
(Amresco, LLC), 10 mM Sodium Bicarbonate (Macron), 5% Horse serum (Sigma), 10 µg/mL Insulin
(Sigma), 10 ng/mL Epidermal Growth Factor (EGF) (Gold Biotechnology), 0.5 µg/mL hydrocortisone
(Sigma), 100 ng/mL cholera toxin (Sigma), and 1% antibiotics (100 units/ml penicillin and 100 g/ml
streptomycin; Corning Mediatech) at 37 °C in a humidified atmosphere in a 5% CO2 incubator.
MCF10A T1K were authenticated by STR DNA profiling at Bio-Synthesis (Lewisville, TX) and cultured in
DMEM (Corning Mediatech) supplemented with 10% fetal bovine serum (J R Scientific) 1% L-glutamine
(Corning Mediatech), 1% antibiotics (100 units/ml penicillin and 100 g/ml streptomycin; Corning
Mediatech), and 1% Sodium Pyruvate (Corning Mediatech) at 37 °C in a humidified atmosphere in a 5%
CO2 incubator.
NMuMG cells were purchased from ATCC and used within 6 months of purchase and 15 passages. Cells
were grown in DMEM (Corning Mediatech) supplemented with 10% fetal bovine serum (J R Scientific), 10
µg/mL Insulin (Sigma), 1% L-glutamine (Corning Mediatech), 1% antibiotics (100 units/ml penicillin and
100 g/ml streptomycin; Corning Mediatech), and 1% Sodium Pyruvate (Corning Mediatech) at 37 °C in a
humidified atmosphere in a 5% CO2 incubator.
MDCK cells were purchased from ATCC and used within 6 months of purchase and 10 passages. Cells
were cultured in DMEM (Corning Mediatech) supplemented with 10% fetal bovine serum (J R Scientific),
1% L-glutamine (Corning Mediatech), 1% antibiotics (100 units/ml penicillin and 100 g/ml streptomycin;
Corning Mediatech), 1% nonessential amino acids (Corning Mediatech), 10 mM Hepes (HyClone) and
1% Sodium Pyruvate (Corning Mediatech), at 37 °C in a humidified atmosphere in a 5% CO2 incubator.
Caki2 cells were originally purchased from ATCC and subsequently authenticated by STR DNA profiling
at Bio-Synthesis (Lewisville, TX). Cells were grown in McCoy’s 5A medium (Corning Mediatech)
supplemented with 10% fetal bovine serum (J R Scientific), 1% antibiotics (100 units/ml penicillin and 100
g/ml streptomycin; Corning Mediatech), 1% nonessential amino acids (Corning Mediatech), and 1% Lglutamine (Corning Mediatech) at 37 °C in a humidified atmosphere in a 5% CO2 incubator. Caki2 Fuw
and Caki2 Fuw+PBRM1 cells were cultured in the presence of doxycycline (1 µg/ml final concentration).
All the media were supplemented with 1:10,000 dilution of Plasmocin™ (InvivoGen).
Cell culture and treatments
Cells were seeded 24-72 h before treatment such that they were 50-80 % confluent at the time of
experiment. For hydrogen peroxide treatment, indicated concentrations of freshly prepared hydrogen
peroxide were added to the treatment groups for the indicated time periods in their regular media. For
glucose starvation studies, the regular media was replaced with glucose free DMEM media (Corning
Mediatech) or reduced glucose media for the indicated time periods. Following the completion of

treatment, cells were washed once with PBS, harvested by trypsinization and either processed
immediately or flash frozen and stored at -80 oC for future use.
Generation of cell lines
Knockdown was performed using shRNA-mediated knockdown with lentiviral construct pLKO.1. The
shRNA constructs contain the following mature antisense sequences:
Human PBRM1: (TRCN0000015994) TTTGTAGATCAAAGACTCCGG
Mouse PBRM1: (TRCN0000081820) TTCTAGGTTGTATGCCTGTCG
Mouse Brd7 Clone ID: (TRCN0000030015) ATAATCATGGAGTAGCCAGGC
Mouse Brg1: (TRCN0000071386) TTCTCAATAATGTGTCGGGCG
Mouse Arid1a: (TRCN0000071395, Origene TG517733) ATTGTAGGTCATGTCATTTCG
Canine PBRM1-1: ACATCATCATACTCTTCCA
Canine PBRM1-2: ACCAACAGCCATACAACCA
c-Jun (TRCN0000042695): GCTTAAGCAGAAAGTCATGAAC
NRF2 (TRCN0000054658):GCCAAAGCTAGTATAGCAATAA
Caki2 FUW vector and Caki2 FUW PBRM1 as described in Chowdhury et al. 2016.
Short guide RNA for mouse PBRM1 (sgPBRM1) was designed using the MIT CRISPR tool
(http://crispr.mit.edu/) and the control sgRNA (sgControl) was taken from Alpsoy and Dykhuizen et al.
2018 (Alpsoy and Dykhuizen, 2018).
Mouse sgControl: GTAGCGAACGTGTCCGGCGT
Mouse sgPBRM1: TTCATCCTTATAGTCTCGGA
The sgRNA were ordered as single strand oligos, annealed and cloned into vector PX459 (pSpCas9(BB)2A-Puro (PX459) V2.0 was a gift from Feng Zhang, Addgene plasmid # 62988). The constructs were
introduced into NMuMG cells by transient transfection using Lipofectamine 3000 (Invitrogen). After 48 h of
transfection, selection using puromycin (0.6 µg/ml) was done for 48 h. The efficiency of knockout
constructs was confirmed by immunoblotting.
Lentiviral Infection
HEK293T cells were transfected with knockdown and knockout lentivirus constructs along with packaging
vectors pMD2.G and psPAX2. After 48 h, the supernatant was collected and concentrated by
ultracentrifugation (17,300 rpm for 2 h) and resuspended in 200 µl of PBS. Cells were infected with
concentrated virus using spinfection (1500 rpm in swing bucket centrifuge for 1 h). Fresh medium was
added 16 h after infection, and cells were allowed to recover for 24 h before selection. Cells were selected
for 2 weeks with puromycin (0.6 µg/ml) (Sigma-Aldrich) and hygromycin (200 µg/ml) where applicable
(Corning Mediatech). Caki2 cells were cultured with 2 µg/ml doxycycline (EMD Chemicals) for 72 h prior to
experiments to induce protein expression which was confirmed by immunoblotting. The efficiency of all
constructs was confirmed by immunoblotting.
3D culture
Cells were embedded between 2 layers of Cultrex® Basement Membrane Extract (BME) (R&D Systems)
on 8-well Chamber Slide. Wells were pre-coated with BME (200 μl/well) to allow polymerization at 37°C
for 15 minutes. Cells were then seeded at 20,000 cells/well density. After attachment (30 minutes at
37°C), cells were covered with a second layer of BME/culture medium (1:19, 5%) to polymerize overnight
at 37°C. Cells were incubated for 10 days, and the medium was replenished every 3 days. At the end of
incubation, cells were fixed and subjected to immunofluorescence analysis.
Immunofluorescence staining
Cells were washed twice with ice-cold PBS, added 2-3 volumes of ice-cold PBS-EDTA and shaken on ice
for 15-30 minutes. BME was detached from the bottom of culture surface by gently scraping the bottom
with a pipette tip. The solution was transferred to a conical tube and gently shaken on ice for 15-30
minutes. When BME was dissolved completely, the solution was centrifuged at 120g for 1-2 minutes. The
supernatant was carefully aspirated, and cells were gently resuspended in the remaining supernatant.

Pipetted approximated 15 μl of the cell suspension onto a glass bottom dish, allowed cells to settle and
adhere to the glass. Cells were fixed using formalin for 20 minutes at room temperature (RT). Next, cells
were permeabilized with 0.5% Triton X-100 in PBS for 5 minutes at RT and washed 3 times with 100 mM
glycine in PBS at RT. Fixed cells were blocked for 1.5 hours with 10% goat serum. Cells were incubated
overnight at 4°C with primary antibodies. The primary antibodies used were as follows: rat anti–α6-integrin
(Millipore; 1:100 in 0.2% Triton X-100, 0.1% BSA, 0.05% Tween 20 in PBS) and rabbit anti–Zo-1
(Invitrogen, 1:100 in 0.2% Triton X-100, 0.1% BSA, 0.05% Tween 20 in PBS). Cells were incubated with
secondary antibody for 1 hour, followed by 3 washes at RT. Secondary antibodies were as follows: FITC
goat anti-rat and Biotin-SP-conjugated AffiniPure goat anti-rabbit (Jackson ImmunoResearch). Cells were
incubated with Texas Red Avidin D (Vector) for 1hour. Cell nuclei were counterstained with DAPI for 10
minutes and washed 3 times with PBS. Cells were incubated in PBS and imaged by confocal microscopy.
Confocal microscopy
Confocal laser scanning microscopy experiments were conducted using the Zeiss LSM 880 Upright
Confocal.
TopFlash Reporter Assay
NMuMG cells were transfected with 10:1 ratio of M50 Super 8x TopFlash (Addgene 12456) to
pcDNA3.1.CMV-renilla-Neo. The cells were transfected using Lipofectamine with 3:1 ratio of total DNA to
lipofectamine reagent. After 24 h, the cells were trypsinized and 20,000 cells/well were plated in 96-well
white tissue culture treated plates. After an additional 24 h of growth, the firefly and renilla luciferase
levels were measured using the Dual Glo® assay system (Promega).
Annevin V Apoptosis detection in NMuMG cells
NMuMG cells were seeded at a density of ~ 1.5 X 106 cells/60mm dish and cultured for 24 h. The cells
were then given treatments of 200 µM H2O2 in media for 0-4 h, followed by cell harvesting using Accutase
(Innovative cell technologies) and apoptosis detection using the FITC Annexin V apoptosis detection kit
(BD Pharmingen, Cat. # 556547) as per the manufacturer’s instructions. The cells were immediately
analyzed by flow cytometry using the Guava EasyCyte Benchtop Flow Cytometer (Millipore Sigma). The
results were analyzed using FlowJo software.
Immunoblotting
Cells were given treatments as described before for the indicated time periods, followed by cell harvesting
by trypsinization. Whole cell extracts were prepared by dissolving the cell pellets in RIPA buffer (50 mM
Tris (pH 8.0), 150 mM NaCl, 0.1% SDS, 0.5% Na Deoxycholate, 1% NP-40) supplemented with freshly
added PMSF, aprotinin, leupeptin and pepstatin, and incubation for 30 min at 4 oC. The lysates were
centrifuged at 13000 x g for 30 min at 4 °C and the supernatants were preserved. Protein concentration
estimations for the supernatants were done using BCA protein assay kit (Pierce Biotechnology) with BSA
as standard and whole cell extracts were run on a 4-12 % bis-tris gradient protein gel, transferred to
PVDF membrane and probed with primary antibodies in 5% BSA at 4 °C for 16 h.
Antibodies
Cleaved PARP (Asp214) (7C9) (Mouse specific) Cell Signaling #9548
Cleaved PARP (Asp214) (Human Specific) Cell Signaling #9541
PBRM1 (Bethyl Laboratories-PBRM1 Antibody, #A301-591A)
β-actin (Santa Cruz Biotechnology, #sc-47778)
BRG1 (G-7) Santa Cruz sc-17796
BRD7 Bethyl A302-304A
Vimentin BD Biosciences 550513
E-Cadherin BD Biosciences 610182
GAPDH (6C5) (Santa Cruz sc-32233)
LaminB (A-11) sc-377000
Phospho-Akt (Ser473) (D9E) XP® (Cell Signaling #4060)
Migration assay

NMuMG cells were seeded at a density of ~ 1.5 X 106 cells/well in a 6-well plate and cultured for 24 h,
after which scratches were made in each well. The migration of cells was followed at regular intervals as
indicated.
H2-DCFDA staining for intracellular ROS using flow cytometry
NMuMG cells were seeded at a density of ~ 2 x 106 cells/60mm dish and Caki2 cells were seeded at a
density of ~ 3 X 106 cells/60mm dish. The cells were cultured for 48 h, harvested by trypsinization,
washed once with PBS and stained for intracellular ROS by incubation with freshly prepared 10 µM H2DCFDA (Invitrogen, Cat. # D399) in PBS for 30 min at 37 °C in dark. Following the incubation, the cells
were centrifuged at 250 x g for 5 min, resuspended in PBS and immediately analyzed by flow cytometry.
The results were analyzed using FlowJo software.
Stress treatments and H2-DCFDA staining using microplate reader
NMuMG cells were seeded at a density of 6.0 x 104 cells/well and Caki2 cells were seeded at a density of
2.5X104 cells/well in a 96-well black tissue culture plates. The cells were cultured for 24 h, following which
they were subjected to the following stress conditions: H2O2 treatment (0-200 µM for NMuMG and 0-800
µM for Caki2) for 1h followed by 10 min recovery in PBS, glucose starvation by culturing in various
glucose concentrations for 16 h for NMuMG and culturing in glucose free media for the indicated time
periods for Caki2, CoCl2 treatment (0-250µM) for 24h or doxorubicin treatment (0-10 µM) for 24h. At the
end of the treatments, cells were washed once with PBS, and stained with freshly prepared 10 µM H2DCFDA (Invitrogen, Cat. # D399) in PBS for 30 min at 37 °C in dark. Cells were washed again 2x with
PBS and fluorescence measurements were taken using a microplate reader at excitation/emission
wavelengths of 485/530 nm. Unstained cells were used as the negative controls.
H2O2 detection assay
H2O2 levels were measured using Amplex® Red Hydrogen Peroxide/Peroxidase Assay kit (Invitrogen).
The H2O2 levels were determined from whole cell lysates (in RIPA) according to manufacturer’s
instruction. The concentration of H2O2 was determined for lysates generated from 5,000 and 10,000 cells
in 50 µL by plotting fluorescence levels against experimentally determined dose curves.
Viability assays using CellTiter-Glo®
Cells were plated in 96-well white tissue culture plates and cultured for the indicated time under the
indicated conditions. Antioxidant rescue experiments were performed with fresh media daily containing 20
µg/mL Vitamin C or 250 µM N-acetylcysteine (NAC). CellTiter-Glo® assay reagent was added directly to
cells as per manufacturer’s instructions, incubated for 10 min, and the luminescence was measured on a
GloMax® microplate reader.
LDH assays using LDH Cytotoxicity Assay Kit II (Abcam, ab65393)
NMuMG cells were seeded at a density of 6.0 x 104 cells/well and Caki2 cells were seeded at a density of
1.0 x 104 cells/well in 96-well tissue culture plates. The cells were cultured for 24 h, following which they
were subjected to H2O2 treatment (0-300 µM for NMuMG) for 6h or 24h and 200 µM H2O2 for Caki2 for
the indicated time periods. Media was harvested from wells (10 µL) and transferred to a separate 96-well
assay plate along with negative control (media alone) and positive control (lysed cells). LDH Reaction Mix
(100 μl) was added to each well, mixed and incubated for 30 min at room temperature. The absorbance
at 490 nm was measured on the GloMax® microplate reader.
H2-DCFDA staining for MCF10A and MCF10A-T1K followed by flow cytometry
MCF10A and MCF10A-T1K cells were seeded in 60mm dishes in MCF10A media and cultured for 48 h
such that they reach 50-80 % confluency at the day of the experiment. The cells were then harvested
using trypsin, washed once using serum-free and phenol red-free media and stained for intracellular ROS
with freshly prepared 10 µM H2-DCFDA in PBS-Glucose (1X PBS supplemented with 25 mM glucose) as
described before. The cells were immediately examined by flow cytometry and the results were analyzed
using FlowJo software.
RNA-seq

RNA isolation, library construction, sequencing and transcriptome analysis was performed as described in
our previous publication (Chowdhury et al. 2016). Sequencing was performed in biological triplicates.
RNA-seq of NMuMG epithelial cell lines was performed at the Purdue Genomics Core using Illumina
HiSeq technology. The resulting reads were trimmed using Trimmomatic utility (Bolger et al., 2014) and
mapped to mm9 using STAR (Dobin et al., 2013) using default parameters. Read counts
were obtained using HTSeq-count (Anders et al., 2015) in conjunction with a standard gene annotation
files from UCSC (University of California Santa Cruz; http://genome.ucsc.edu) and differential expression
was determined using DESeq2 pipeline (Love et al., 2014). Differentially expressed genes were filtered
using a false discovery rate threshold of < 0.05 and a fold change threshold of > 1.3-fold relative to the
reference sample. Gene ontology and transcription factor prediction analyses were performed using
GeneCodis (Nogales-Cadenas et al., 2009) iCisTarget (Herrmann et al., 2012), and ToppCluster (Kaimal
et al., 2010). Data sets generated in these experiments are available at the Gene Expression Omnibus
under accession number GSE113606.
ATAC-seq
The ATAC-seq protocol originally described (Buenrostro et al., 2015) was adapted as follows for HK2 and
NMuMG isogenic lines: 50,000 cells were resuspended in Nuclei Lysis buffer containing 0.05% IGEPAL
CA-630, incubated for 5 minutes on ice and centrifuged for 10 minutes at 500xg at 4 °C. Nuclei extraction
was confirmed by microscopic inspection and the nuclei pellet was resuspended in transposition master
mix. Tagmentation, cleanup of tagmented DNA, and PCR enrichment was performed as per original
description. High throughput sequencing was performed by HiSeq2500 using 50 bp paired-end at the
Purdue Genomics Core. Sequenced reads were mapped by the Bowtie2 aligner (Ben Langmead et al.,
2009) using hg19 or mm10 reference genome, respectively. Reads mapping to the mitochondrial genome
were discarded. Bigwig files were generated for visual inspection of tracks using the bamCoverage utility
of deepTools (Ramírez et al., 2016). Peaks of differential accessibility were identified using the SICER-dfrb utility (Xu et al., 2014) with a false discovery rate threshold of < 0.05 and a fold change threshold of >
1.5-fold difference in accessibility. Scaled heat maps were generated for the peak regions using the
computeMatrix and plotHeatmap utilities of deepTools. Peak regions were analyzed for enrichment of
sequence motifs and association with genomic elements using the findMotifs and annotatePeaks utilities
of HOMER (Heinz et al., 2010).
qRT-PCR
RNA was isolated from cells using Trizol (Ambion, Thermofisher). Total RNA was converted to cDNA with
Verso cDNA Synthesis Kit according to manufacturer’s instructions (Thermo Scientific). Real-time PCR
was performed using a Bio-Rad CFX Connect Real-Time system and Thermo Scientific Maxima SYBR
Green qPCR Master Mix (Thermo Scientific). The results were analyzed using the Pfaffl method (Pfaffl,
2001).
Gene
c-Jun
BCL2L1
HK2
IL1RL1
NRF2
HMOX1
NQO1
BMF
ATF3
IGFBP4
BCL2

Forward Primer
ACTCGGACCTTCTCACGTC
GACAAGGAGATGCAGGTATTGG
TGATCGCCTGCTTATTCACGG
ACGCTCGACTTATCCTGTGG
GATCCGCCAGCTACTCCCAGGTTG
GCCGAGAATGCTGAGTTCATG
CGCCTGAGCCCAGATATTGT
GTGGCAACATCAAGCAGAGG

CTGCAGAAAGAGTCGGAG
CTCTTCCGGTGCTGACCTCT
CTGCACCTGACGCCCTTCACC

Reverse Primer
GGTCGGTGTAGTGGTGATGT
TCCCGTAGAGATCCACAAAAGT
AACCGCCTAGAAATCTCCAGA
CAGGTCAATTGTTGGACACG
CAGGGCAAGCGACTCATGGTCATC
TGGTACAAGGAAGCCATCACC
GCACTCTCTCAAACCAGCCT
CGGTGGAACTGGTCTGCAA
TGAGCCCGGACAATACAC
GGTGCTCCGGTCTCGAAT
CACATGACCCCACCGAACTCAAAGA

TCGA analysis
TCGA data analysis was performed as described in Chowdhury et al. 2016.
Data and software availability

Data sets generated in these experiments are available at the Gene Expression Omnibus under
accession number GSE113606.
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